Birla Institute of Technology & Science, Pilani (BITS Pilani) is a Deemed to be University established vide Sec.3 of the UGC Act,1956. It has established itself as a symbol of Excellence and has been declared as an Institution of Eminence (IoE) by the Ministry of Education, Government of India in 2020. It offers Undergraduate, Graduate, and PhD programmes to over 17,000 students across its campuses in Pilani, Dubai, Goa, Hyderabad, and Mumbai. QS World University Subject Rankings 2022 has ranked BITS Pilani globally at 101-150 in Pharmacy and Pharmacology. BITS Pilani has also been ranked among the top 300 in QS World University Graduate Employability Rankings 2022 and within the top 8 in India. In QS Asia University Rankings 2021, BITS has been ranked 194th (only private institute from India in the Asia Top 200, and at 18 in India).
Post : Research Associates
About DBT Boost to University Interdisciplinary Life Science Departments for Education and Research (DBT BUILDER) programme
The DBT BUILDER programme fosters interaction between the existing departments of universities invigorating interdisciplinary modern bioscience research through creation of new research agenda aiming to develop world-class school of life science in universities doing both advanced research and education.
RESEARCH THEME
The theme of DBT BUILDER at BITS Pilani, Pilani campus is "Interdisciplinary Life Science Programme for Advanced Research and Education in Epigenetics and Genome editing”
Fellowship : 47,000 /- p.m. + HRA (as per DBT norms)
Epigenetics [Diabetes] Research Area
Department : Department of Pharmacy / Biological Sciences
Investigators : Prof. Syamantak Majumdar & Prof. Anil Gaikwad
No. of Positions : 1
Essential Qualification : The applicants should hold a Ph.D. Degree in Pharmaceutical Sciences, Pharmacology, Biotechnology and Life Sciences preferably, with research interests in RNA therapeutics and Diabetic Kidney Diseases.
• Proficiency in English with good communication skills is also a major criteria.
Desirable Qualification : Candidate with experience to use primary cell culture systems and animal models in combination with high throughput RNA sequencing, ribosome-profiling, CLIP-seq, and flow cytometry methods to study how long noncoding RNAs control gene expression under normal and pathological conditions in diabetic kidney diseases. Candidate should have expertise in molecular and cellular pharmacology and epigenetics. Evidence of scientific publications is required and previous experience with RNA molecular biology and bioinformatics skills are desirable
For queries contact at following email ID: dbtbuilder@pilani.bits-pilani.ac.in
Deadline for application is 18th July & ttentative period of online interviews is fourth week of July
Selected candidates are expected to join the programme by August 2022
See All Pilani Alerts D.Pharm Alerts B.Pharm Alerts B.Sc Alerts
See All Other Jobs in our Database
.png)
